Cancer Gene Signals Drive Tumor Growth in a Carcinoma Model

Greg Howard
29th April, 2025

Cancer Gene Signals Drive Tumor Growth in a Carcinoma Model

Oncogenic RasV12 drives the aberrant accumulation of two distinct NF-κB Dorsal isoforms, Dorsal-A and Dorsal-B, in separate, non-overlapping cell populations within Drosophila tumors (a, b), creating a heterogeneous expression pattern with both broadly elevated and highly localized zones (c, d).

Image adapted from: Dillard et al. / CC BY (Source)

Key Findings

  • Researchers at Fred Hutchinson Cancer Research Center used fruit flies to discover that specific inflammation-related proteins are crucial for tumor growth
  • They found that high levels of NF-κB proteins in cancer cells enhance their ability to invade surrounding tissues
  • The study identified interactions between proteins Dorsal and Chinmo that help cancer cells survive and spread, pointing to new treatment targets
Cancer progression and its response to treatment are deeply influenced by the body's inflammatory processes. Chronic inflammation can promote tumor growth and resistance to therapies, while acute inflammatory reactions may enhance the immune system's ability to fight cancer[2]. Understanding the molecular mechanisms that govern these processes is crucial for developing more effective cancer treatments. A recent study from the Fred Hutchinson Cancer Research Center[1] sheds light on how cancer-driving mutations interact with inflammatory signaling pathways to facilitate tumor growth and malignancy. Using the fruit fly, Drosophila melanogaster, as a model, researchers investigated the role of the Toll-NF-κB signaling pathway in cancer progression. This pathway, initially discovered in Drosophila for its roles in development and immunity, has been less explored in the context of cancer. The study focused on a specific tumor model driven by the cooperative action of the RasV12 oncogene and the loss of the scribble gene (scrib-), which is known to contribute to tumorigenesis. The researchers found that components of the Toll pathway, including extracellular elements ModSP and PGRP-SA and the intracellular kinase Pelle/IRAK, are critical for tumor growth. These components act as rate-limiting factors, meaning their presence is essential for the tumors to develop effectively. One of the key findings was the elevated expression of the NF-κB protein Dorsal and its inhibitor, cactus/IκB, in tumors. Notably, the highest levels were observed in invasive cell populations within the tumors, suggesting a link between Toll-NF-κB signaling and the ability of cancer cells to invade surrounding tissues. This aligns with previous research indicating that NF-κB plays a significant role in cancer prognosis. For instance, higher NF-κB expression has been associated with poorer outcomes in non-small cell lung cancer patients, correlating with advanced tumor stages and increased metastasis[3]. Further analysis revealed that the oncogenic RasV12 mutation, rather than the loss of scribble, leads to increased and heterogeneous expression of two Dorsal isoforms, DorsalA and DorsalB, within different tumor cell populations. This heterogeneity suggests that different subsets of cancer cells may utilize the Toll-NF-κB pathway in distinct ways to promote tumor growth and survival. The study also demonstrated that Dorsal works in concert with the BTB-transcription factor Chinmo to drive tumor growth and malignancy. This partnership suppresses cell differentiation, inhibits programmed cell death (apoptosis), and promotes the invasive capabilities of the tumor cells. These findings build upon earlier studies that have highlighted the importance of inflammatory signaling in cancer. Chronic inflammation is known to create a tumor-friendly environment by supporting various stages of cancer development, from initiation to metastasis[2]. Additionally, abnormal activation of signaling pathways like NF-κB is a common feature in many cancers, contributing to their growth and resistance to treatments[4]. The current study provides new insights by demonstrating how specific components of the Toll-NF-κB pathway interact with oncogenic mutations to drive cancer progression. The use of Drosophila as a model organism is particularly advantageous due to its genetic tractability and the conservation of many biological pathways between flies and humans. This approach allows researchers to dissect complex molecular interactions in a simplified system, offering potential avenues for translating these findings into human cancer research. By identifying key regulators like ModSP, PGRP-SA, Pelle/IRAK, and Dorsal, the study points to possible targets for therapeutic intervention. Modulating these components could disrupt the pro-tumorigenic signaling cascade, potentially hindering tumor growth and spread. Moreover, the study's discovery of the interplay between Dorsal and Chinmo adds another layer of complexity to our understanding of cancer biology. Targeting such interactions could offer more precise strategies to interfere with cancer cell survival and invasiveness. This is particularly relevant given the challenges posed by treatment-resistant cancer cells, which often exploit these signaling pathways to evade conventional therapies[4]. In summary, the research from the Fred Hutchinson Cancer Research Center advances our comprehension of how inflammatory signaling pathways, specifically Toll-NF-κB, cooperate with cancer-driving mutations to promote tumor growth and malignancy. By leveraging Drosophila models, the study uncovers critical molecular interactions that could inform the development of targeted cancer therapies, offering hope for more effective treatments in the future.

GeneticsBiochemAnimal Science

References

Main Study

1) NF-κB signaling driven by oncogenic Ras contributes to tumorigenesis in a Drosophila carcinoma model

Published 28th April, 2025

https://doi.org/10.1371/journal.pbio.3002663

Related Studies

2) Inflammation and tumor progression: signaling pathways and targeted intervention.

https://doi.org/10.1038/s41392-021-00658-5

3) Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis.

https://doi.org/10.1371/journal.pone.0198223

4) Role of the NFκB-signaling pathway in cancer.

https://doi.org/10.2147/OTT.S161109


Related Articles

An unhandled error has occurred. Reload 🗙